RT Journal Article
SR Electronic
T1 COVID-19 among migrants, refugees, and internally displaced persons: systematic review, meta-analysis and qualitative synthesis of the global empirical literature
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.08.03.23293586
DO 10.1101/2023.08.03.23293586
A1 Hintermeier, Maren
A1 Gottlieb, Nora
A1 Rohleder, Sven
A1 Oppenberg, Jan
A1 Baroudi, Mazen
A1 Pernitez-Agan, Sweetmavourneen
A1 Lopez, Janice
A1 Flores, Sergio
A1 Mohsenpour, Amir
A1 Wickramage, Kolitha
A1 Bozorgmehr, Kayvan
YR 2023
UL http://medrxiv.org/content/early/2023/08/06/2023.08.03.23293586.abstract
AB Background Pandemic response and preparedness plans aim at mitigating the spread of infectious diseases and protecting public health, but migrants are often side-lined. Evidence amounted early that migrants are disproportionately affected by the COVID-19 pandemic and its consequences. However, synthesised evidence is lacking that quantifies the inequalities in infection risk and disease outcomes, or contextualises the consequences of pandemic measures and their underlying mechanisms.Methods Systematic review searching 25 databases and grey literature (12/2019 to 11/2021). We considered empirical articles covering migrants, refugees, asylum-seekers, and internally displaced persons reporting SARS-CoV-2 cases, hospitalisation, ICU admission, mortality, COVID-19 vaccination rates or health consequences of pandemic measures. Random-effects meta-analysis of observational studies and qualitative analysis were performed for evidence synthesis. A Protocol was registered with PROSPERO (CRD42021296952).Findings Out of 6956 studies, we included 241 in the review. For the quantitative studies (n=46), meta-analysis with over 40 million study participants showed that compared to non-migrants, migrants have an elevated risk of infection (RR = 2·33; 95%-CI: 1·88-2·89) but similar risk for hospitalisation (RR = 1·05; 0·80-1·37), while the likelihood of ICU admission was higher (RR = 1·36; 1·04-1·78). Among those hospitalised, migrants had a lower risk of mortality (RR = 0·47; 0·30-0·73), while their population-based excess mortality tended to be higher (RR = 1·31; 0·95-1·80). The qualitative synthesis (n=44) highlighted the complex interplay of social and COVID-19-related factors at different levels. This involved increased exposure, risk, and impact of pandemic measures that compromised the health of migrants.Interpretation Even in the advanced stages of the pandemic, migrants faced higher infection risks and disproportionately suffered from the consequences of COVID-19 disease, including deaths. Population-level interventions in future health emergencies must better consider socio-economic, structural and community-level exposures to mitigate risks among migrants and enhance health information systems, to close coverage gaps in migrant groups.Funding None.Competing Interest StatementAM, KB, MH, SF received an individual honorarium from IOM. All authors declare no competing interests.Clinical Protocols https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=296952 Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes